Efficacy of tildrakizumab on itching, pain and fatigue in patients with moderate to severe psoriasis: 52-week results of the real-world study POSITIVE

U Mrowietz; M Augustin; Z Reguiai; S Gerdes; E Dauden; Wolfgang Weger; JT Maul; P Laws; L Naldi; PD Ghislain; E de Jong; S Mburu; V Koscielny; E Massana; I Kasujee; A Kirsc; R Sommer

Efficacy of tildrakizumab on itching, pain and fatigue in patients with moderate to severe psoriasis: 52-week results of the real-world study POSITIVE

U Mrowietz
, M Augustin
, Z Reguiai
, S Gerdes
, E Dauden
, Wolfgang Weger
, JT Maul
, P Laws
, L Naldi
, PD Ghislain
, E de Jong
, S Mburu
, V Koscielny
, E Massana
, I Kasujee
, A Kirsc
, R Sommer

Department of Dermatology and Venereology

Research output: Contribution to journal › Conference abstract

Original language	German (Austria)
Number of pages	1
Journal	JDDG - Journal of the German Society of Dermatology
Volume	23
Publication status	Published - Apr 2025
Event	53. Tagung der Deutschen Dermatologischen Gesellschaft - Berlin, Germany Duration: 30 Apr 2025 → 3 May 2025

Branches of science

302 Clinical Medicine

Links

Web of Science

Efficacy of tildrakizumab on itching, pain and fatigue in patients with moderate to severe psoriasis: 52-week results of the real-world study POSITIVE
Mrowietz, U. (Author), Augustin, M. (Author), Reguiai, Z. (Author), Gerdes, S. (Author), Dauden, E. (Author), Weger, W. (Author), Maul, J. (Author), Laws, P. (Author), Naldi, L. (Author), Ghislain, P. (Author), de Jong, E. (Author), Mburu, S. (Author), Koscielny, V. (Author), Massana, E. (Author), Kasujee, I. (Author), Kirsc, A. (Author) & Sommer, R. (Author)
2025
Activity: Talk, presentation or poster › Poster

Cite this

Mrowietz, U., Augustin, M., Reguiai, Z., Gerdes, S., Dauden, E., Weger, W., Maul, JT., Laws, P., Naldi, L., Ghislain, PD., de Jong, E., Mburu, S., Koscielny, V., Massana, E., Kasujee, I., Kirsc, A., & Sommer, R. (2025). Efficacy of tildrakizumab on itching, pain and fatigue in patients with moderate to severe psoriasis: 52-week results of the real-world study POSITIVE. JDDG - Journal of the German Society of Dermatology, 23.

@article{f12a9786221f4e54a79a55e92767e9cf,

title = "Efficacy of tildrakizumab on itching, pain and fatigue in patients with moderate to severe psoriasis: 52-week results of the real-world study POSITIVE",

author = "U Mrowietz and M Augustin and Z Reguiai and S Gerdes and E Dauden and Wolfgang Weger and JT Maul and P Laws and L Naldi and PD Ghislain and \{de Jong\}, E and S Mburu and V Koscielny and E Massana and I Kasujee and A Kirsc and R Sommer",

year = "2025",

month = apr,

language = "Deutsch ({\"O}sterreich)",

volume = "23",

journal = "JDDG - Journal of the German Society of Dermatology",

issn = "1610-0379",

publisher = "Wiley-Blackwell Publishing Ltd",

note = "53. Tagung der Deutschen Dermatologischen Gesellschaft, DDG 53 ; Conference date: 30-04-2025 Through 03-05-2025",

}

Mrowietz, U, Augustin, M, Reguiai, Z, Gerdes, S, Dauden, E, Weger, W, Maul, JT, Laws, P, Naldi, L, Ghislain, PD, de Jong, E, Mburu, S, Koscielny, V, Massana, E, Kasujee, I, Kirsc, A & Sommer, R 2025, 'Efficacy of tildrakizumab on itching, pain and fatigue in patients with moderate to severe psoriasis: 52-week results of the real-world study POSITIVE', JDDG - Journal of the German Society of Dermatology, vol. 23.

TY - JOUR

T1 - Efficacy of tildrakizumab on itching, pain and fatigue in patients with moderate to severe psoriasis: 52-week results of the real-world study POSITIVE

AU - Mrowietz, U

AU - Augustin, M

AU - Reguiai, Z

AU - Gerdes, S

AU - Dauden, E

AU - Weger, Wolfgang

AU - Maul, JT

AU - Laws, P

AU - Naldi, L

AU - Ghislain, PD

AU - de Jong, E

AU - Mburu, S

AU - Koscielny, V

AU - Massana, E

AU - Kasujee, I

AU - Kirsc, A

AU - Sommer, R

PY - 2025/4

Y1 - 2025/4

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:001515598600076

M3 - Konferenzabstract

SN - 1610-0379

VL - 23

JO - JDDG - Journal of the German Society of Dermatology

JF - JDDG - Journal of the German Society of Dermatology

T2 - 53. Tagung der Deutschen Dermatologischen Gesellschaft

Y2 - 30 April 2025 through 3 May 2025

ER -

Efficacy of tildrakizumab on itching, pain and fatigue in patients with moderate to severe psoriasis: 52-week results of the real-world study POSITIVE

Branches of science

Links

Activities

Efficacy of tildrakizumab on itching, pain and fatigue in patients with moderate to severe psoriasis: 52-week results of the real-world study POSITIVE

Cite this